{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:17:00Z","timestamp":1789208220019,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cyto.2020.155297","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T03:00:37Z","timestamp":1600743637000},"page":"155297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A historical review of the role of cytokines involved in leishmaniasis"],"prefix":"10.1016","volume":"145","author":[{"given":"Asad","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-6598","authenticated-orcid":false,"given":"Nahid","family":"Maspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155297_b0005","unstructured":"WHO, Leishmaniasis. World Health Org Fact Sheet., (2 March 2020)."},{"key":"10.1016\/j.cyto.2020.155297_b0010","doi-asserted-by":"crossref","unstructured":"J. Alvar, I.D. V\u00e9lez, C. Bern, M. Herrero, P. Desjeux, J. Cano, J. Jannin, M. den Boer, W.L.C. Team, Leishmaniasis worldwide and global estimates of its incidence, PloS one 7(5) (2012).","DOI":"10.1371\/journal.pone.0035671"},{"issue":"9","key":"10.1016\/j.cyto.2020.155297_b0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155297_b0020","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"10.1016\/j.cyto.2020.155297_b0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","article-title":"Pro-and anti-inflammatory cytokines in cutaneous leishmaniasis: a review","volume":"110","author":"Maspi","year":"2016","journal-title":"Pathogens Global Health"},{"issue":"3","key":"10.1016\/j.cyto.2020.155297_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl.Trop. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"issue":"2","key":"10.1016\/j.cyto.2020.155297_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.150.2.359","article-title":"Studies on the mechanisms of macrophage activation. II. Parasite destruction in macrophages activated by supernates from concanavalin A-stimulated lymphocytes","volume":"150","author":"Buchm\u00fcller","year":"1979","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2020.155297_b0045","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI111107","article-title":"Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.","volume":"72","author":"Murray","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155297_b0050","doi-asserted-by":"crossref","unstructured":"E. Kamali-Sarvestani, M. Rasouli, H. Mortazavi, B. Gharesi-Fard, Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients, Cytokine 35(3-4) (2006) 159-65.","DOI":"10.1016\/j.cyto.2006.07.016"},{"key":"10.1016\/j.cyto.2020.155297_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12881-020-01043-9","article-title":"TNF-\u03b1\u2212 308 G\/A and IFN-\u03b3+ 874 A\/T gene polymorphisms in Saudi patients with cutaneous leishmaniasis","volume":"21","author":"Ahmed","year":"2020","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.cyto.2020.155297_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-7-33","article-title":"IFNG +874T\/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production","volume":"7","author":"Matos","year":"2007","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2020.155297_b0065","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4049\/jimmunol.122.3.1134","article-title":"Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages","volume":"122","author":"Handman","year":"1979","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155297_b0070","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.141.3.890","article-title":"Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection","volume":"141","author":"Belosevic","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2020.155297_b0075","article-title":"Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis","volume":"4","author":"Ahmadi","year":"2015","journal-title":"Adv. Biomed. Res."},{"issue":"6","key":"10.1016\/j.cyto.2020.155297_b0080","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1084\/jem.170.6.2097","article-title":"Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis","volume":"170","author":"Titus","year":"1989","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2020.155297_b0085","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.173.4.923","article-title":"Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes","volume":"173","author":"Alderson","year":"1991","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0090","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.4049\/jimmunol.147.7.2234","article-title":"Induction of macrophage inflammatory protein-1 beta gene expression in human monocytes by lipopolysaccharide and IL-7","volume":"147","author":"Ziegler","year":"1991","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2020.155297_b0095","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1128\/iai.61.9.4008-4012.1993","article-title":"Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages","volume":"61","author":"Gessner","year":"1993","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.143.1.266","article-title":"Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H\/HeN mice to infection with Leishmania major","volume":"143","author":"Belosevic","year":"1989","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2020.155297_b0105","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.171.1.115","article-title":"Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism","volume":"171","author":"Sadick","year":"1990","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2020.155297_b0115","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.176.5.1387","article-title":"Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells","volume":"176","author":"D'Andrea","year":"1992","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.cyto.2020.155297_b0120","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.146.9.3074","article-title":"Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells","volume":"146","author":"Wolf","year":"1991","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155297_b0125","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/20477724.2019.1568034","article-title":"Influence of genetic variants of gamma interferon, interleukins 10 and 12 on Visceral Leishmaniasis in an endemic area, Iran","volume":"113","author":"Kalani","year":"2019","journal-title":"Pathogens and Global Health"},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/expr.1996.0003","article-title":"Leishmania major: Infection of Human Monocytes Induces Expression of IL-8 and MCAF","volume":"82","author":"Badolato","year":"1996","journal-title":"Exp. Parasitol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155297_b0140","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.147.6.2006","article-title":"Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani","volume":"147","author":"Weiser","year":"1991","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155297_b0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0966-842X(94)90111-H","article-title":"Macrophage migration inhibitory factor is a neuroendocrine mediator of endotoxaemia","volume":"2","author":"Bernhagen","year":"1994","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.cyto.2020.155297_b0150","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.3.1285","article-title":"Protective Effect on Leishmania major Infection of Migration Inhibitory Factor, TNF-a, and IFN-g Administered Orally via Attenuated Salmonella typhimurium1","volume":"160","author":"Xu","year":"1998","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155297_b0155","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4049\/jimmunol.161.5.2383","article-title":"Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-\u03b1","volume":"161","author":"J\u00fcttner","year":"1998","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cyto.2012.09.012","article-title":"Candidate gene case-control and functional study shows macrophage inhibitory factor (MIF) polymorphism is associated with cutaneous leishmaniasis","volume":"61","author":"de Jesus Fernandes Covas","year":"2013","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0165","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X","article-title":"Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice","volume":"28","author":"Satoskar","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155297_b0170","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20030159","article-title":"Interleukin 1\u03b1 promotes Th1 differentiation and inhibits disease progression in Leishmania major\u2013susceptible BALB\/c Mice","volume":"198","author":"von Stebut","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155297_b0175","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.4049\/jimmunol.163.5.2821","article-title":"Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus Infection in IL-18-deficient mice1","volume":"163","author":"Wei","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155297_b0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1074-7613(01)00206-0","article-title":"WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection","volume":"15","author":"Yoshida","year":"2001","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0185","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.4049\/jimmunol.0804024","article-title":"IL-27 Regulates IL-10 and IL-17 from CD4 + Cells in Nonhealing Leishmania major Infection","volume":"183","author":"Anderson","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2020.155297_b0190","doi-asserted-by":"crossref","unstructured":"S. Milano, G.D. Bella, P. D\u2019agostino, C. Barbera, R. Caruso, M.L. Rosa, V. Ferlazzo, G. Vitale, C.L. Russa, G.J.C. Gambino, E. Immunology, IL\u201015 in human visceral leishmaniasis caused by Leishmania infantum, 127(2) (2002) 360-365.","DOI":"10.1046\/j.1365-2249.2002.01749.x"},{"key":"10.1016\/j.cyto.2020.155297_b0195","doi-asserted-by":"crossref","unstructured":"O. Bacellar, H. Lessa, A. Schriefer, P. Machado, A. Ribeiro de Jesus, W.O. Dutra, K.J. Gollob, E.M. Carvalho, Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients, Infection and Immunity 70(12) (2002) 6734.","DOI":"10.1128\/IAI.70.12.6734-6740.2002"},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0200","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/eji.200635937","article-title":"Distinct roles for IL-6 and IL-12p40 in mediating protection againstLeishmania donovani and the expansion of IL-10+ CD4+ T cells","volume":"36","author":"St\u00e4ger","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0205","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/IAI.00422-06","article-title":"Responses to Leishmania donovani in Mice Deficient in Interleukin-12 (IL-12), IL-12\/IL-23, or IL-18","volume":"74","author":"Murray","year":"2006","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.cyto.2020.155297_b0210","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.201040484","article-title":"A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL\/6 mice","volume":"40","author":"Wu","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"supplement 1","key":"10.1016\/j.cyto.2020.155297_b0215","first-page":"285","article-title":"the survey of the effect of cytokine IL22 on the ulcer originated from l- major in balb\/c mice","volume":"21","author":"Hezarjaribi Ziaee","year":"2012","journal-title":"J. Mazandaran University Of Medical Sciences"},{"issue":"8","key":"10.1016\/j.cyto.2020.155297_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134698","article-title":"IL-22 protects against tissue damage during cutaneous leishmaniasis","volume":"10","author":"Gimblet","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155297_b0225","doi-asserted-by":"crossref","unstructured":"H. Galdino, A.E. Maldaner, L.L. Pessoni, F.M. Soriani, L.I.d.A. Pereira, S.A. Pinto, F.B. Duarte, C.M. Gomes, A.K.A. Fleuri, M.L. Dorta, M.A.P. de Oliveira, M.M. Teixeira, A.C. Batista, L.A.B. Joosten, L.Q. Vieira, F. Ribeiro-Dias, Interleukin 32\u03b3 (IL-32\u03b3) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10, BMC Infectious Diseases 14(1) (2014) 249.","DOI":"10.1186\/1471-2334-14-249"},{"key":"10.1016\/j.cyto.2020.155297_b0230","doi-asserted-by":"crossref","unstructured":"W. Solbach, J. Greil, M. R\u00f6llinghoff, Anti-infectious responses in Leishmania major-infected BALB\/c mice injected with recombinant granulocyte-macrophage colony stimulating factor, Annales de l'Institut Pasteur\/Immunologie, Elsevier, 1987, pp. 759-762.","DOI":"10.1016\/S0769-2625(87)80033-8"},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/eji.1830190712","article-title":"Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis","volume":"19","author":"Liew","year":"1989","journal-title":"Eur J Immunol"},{"issue":"16","key":"10.1016\/j.cyto.2020.155297_b0240","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","article-title":"Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.","volume":"88","author":"Heinzel","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cyto.2020.155297_b0245","doi-asserted-by":"crossref","unstructured":"M. Vieth, A. Will, K. Schr\u00f6ppel, M. R\u00f6llinghoff, A. Gessner, Interleukin\u201010 inhibits antimicrobial activity against Leishmania major in murine macrophages, Scandinavian journal of immunology 40(4) (1994) 403-409.","DOI":"10.1111\/j.1365-3083.1994.tb03481.x"},{"issue":"5069","key":"10.1016\/j.cyto.2020.155297_b0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.1636092","article-title":"Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism","volume":"257","author":"Barral-Netto","year":"1992","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.cyto.2020.155297_b0255","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.162.2.974","article-title":"Anti-TGF-\u03b2 treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production","volume":"162","author":"Li","year":"1999","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2020.155297_b0260","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.7.3682","article-title":"IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages","volume":"151","author":"Hatzigeorgiou","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2020.155297_b0265","doi-asserted-by":"crossref","unstructured":"C. M. Theodos, A. Shankar, A. L. Glasebrook, W. D. Roeder, R. G. Titus, The effect of treating with anti\u2010interleukin\u20101 receptor antibody on the course of experimental murine cutaneous leishmaniasis, Parasite immunology 16(11) (1994) 571-577.","DOI":"10.1111\/j.1365-3024.1994.tb00312.x"},{"key":"10.1016\/j.cyto.2020.155297_b0270","doi-asserted-by":"crossref","unstructured":"S.L. Kostka, J. Knop, A. Konur, M.C. Udey, E. von Stebut, Distinct Roles for IL-1 Receptor Type I Signaling in Early Versus Established Leishmania major Infections, Journal of Investigative Dermatology 126(7) (2006) 1582-1589.","DOI":"10.1038\/sj.jid.5700309"},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0100-879X1998000100020","article-title":"Cytokine profile and pathology in human leishmaniasis","volume":"31","author":"Ribeiro-de-Jesus","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.cyto.2020.155297_b0280","doi-asserted-by":"crossref","unstructured":"A. Ortiz-Flores, G. De la Rosa-L\u00f3pez, B. Zavaleta-Villa, S. Ch\u00e1vez-L\u00f3pez, J. Pastor-Santiago, C. Guzm\u00e1n-Bracho, M. Romero-Valdovinos, F. Mart\u00ednez-Hern\u00e1ndez, A. Olivo-D\u00edaz, Association of leishmaniasis with TNF alpha promoter and SLC11A1 gene polymorphisms in patients of two endemic areas in Mexico, Microbes and infection 17(5) (2015) 387\u201394.","DOI":"10.1016\/j.micinf.2015.01.001"},{"issue":"1","key":"10.1016\/j.cyto.2020.155297_b0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12881-020-01043-9","article-title":"TNF-\u03b1 - 308 G\/A and IFN-\u03b3 + 874 A\/T gene polymorphisms in Saudi patients with cutaneous leishmaniasis","volume":"21","author":"Ahmed","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.cyto.2020.155297_b0290","doi-asserted-by":"crossref","unstructured":"A. Mera-Ram\u00edrez, A. Castillo, Y. Orobio, M.A. G\u00f3mez, C. Gallego-Marin, Screening of TNF\u03b1, IL-10 and TLR4 single nucleotide polymorphisms in individuals with asymptomatic and chronic cutaneous leishmaniasis in Colombia: a pilot study, BMC infectious diseases 17(1) (2017) 177.","DOI":"10.1186\/s12879-017-2281-4"},{"key":"10.1016\/j.cyto.2020.155297_b0295","doi-asserted-by":"crossref","unstructured":"S. Leuenroth, C. Lee, P. Grutkoski, H. Keeping, H.H. Simms, Interleukin-8\u2013induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas\/Apo-1) Fas-l interactions, Surgery 124(2) (1998) 409-417.","DOI":"10.1016\/S0039-6060(98)70148-5"},{"issue":"10","key":"10.1016\/j.cyto.2020.155297_b0300","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.4049\/jimmunol.162.10.6132","article-title":"IL-4-and IL-4 receptor-deficient BALB\/c mice reveal differences in susceptibility to Leishmania major parasite substrains","volume":"162","author":"Noben-Trauth","year":"1999","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2020.155297_b0305","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.4049\/jimmunol.162.12.7302","article-title":"Differences between IL-4-and IL-4 receptor \u03b1-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling","volume":"162","author":"Mohrs","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155297_b0310","doi-asserted-by":"crossref","unstructured":"D.J. Matthews, C.L. Emson, G.J. McKenzie, H.E. Jolin, J.M. Blackwell, A.N. McKenzie, IL-13 is a susceptibility factor for Leishmania major infection, The Journal of Immunology 164(3) (2000) 1458-1462.","DOI":"10.4049\/jimmunol.164.3.1458"},{"key":"10.1016\/j.cyto.2020.155297_b0315","doi-asserted-by":"crossref","unstructured":"A. Ivens, C. Peacock, L. Worthey, L. Murphy, G. Aggarwal, M. Berriman, E. Sisk, M.-A. Rajandream, E. Adlem, R. Aert, A. Anupama, Z. Apostolou, P. Attipoe, N. Bason, C. Bauser, A. Beck, S. Beverley, G. Bianchettin, K. Borzym, P. Myler, The Genome of the Kinetoplastid Parasite, Leishmania major, Science (New York, N.Y.) 309 (2005) 436-42.","DOI":"10.1126\/science.1112680"},{"key":"10.1016\/j.cyto.2020.155297_b0320","doi-asserted-by":"crossref","unstructured":"D. Kamir, S. Zierow, L. Leng, Y. Cho, Y. Diaz, J. Griffith, C. McDonald, M. Merk, R.A. Mitchell, J. Trent, A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses, The Journal of Immunology 180(12) (2008) 8250-8261.","DOI":"10.4049\/jimmunol.180.12.8250"},{"key":"10.1016\/j.cyto.2020.155297_b0325","doi-asserted-by":"crossref","unstructured":"J.M. Richardson, L.S. Morrison, N.D. Bland, S. Bruce, G.H. Coombs, J.C. Mottram, M.D. Walkinshaw, Structures of Leishmania major orthologues of macrophage migration inhibitory factor, Biochemical biophysical research communications 380(3) (2009) 442-448.","DOI":"10.1016\/j.bbrc.2009.01.030"},{"key":"10.1016\/j.cyto.2020.155297_b0330","doi-asserted-by":"crossref","unstructured":"S.L. Kostka, S. Dinges, K. Griewank, Y. Iwakura, M.C. Udey, E. Von Stebut, IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice, The Journal of Immunology 182(5) (2009) 3039-3046.","DOI":"10.4049\/jimmunol.0713598"},{"key":"10.1016\/j.cyto.2020.155297_b0335","doi-asserted-by":"crossref","unstructured":"O. Rostan, J.-P. Gangneux, C. Piquet-Pellorce, C. Manuel, A.N.J. McKenzie, C. Guiguen, M. Samson, F. Robert-Gangneux, The IL-33\/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB\/c Mice Infected with Leishmania donovani, mBio 4(5) (2013) e00383-13.","DOI":"10.1128\/mBio.00383-13"},{"key":"10.1016\/j.cyto.2020.155297_b0340","doi-asserted-by":"crossref","unstructured":"P. Gurung, R. Karki, P. Vogel, M. Watanabe, M. Bix, M. Lamkanfi, T.-D. Kanneganti, An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis, The Journal of clinical investigation 125(3) (2015) 1329-1338.","DOI":"10.1172\/JCI79526"},{"key":"10.1016\/j.cyto.2020.155297_b0345","doi-asserted-by":"crossref","unstructured":"L.M. Sousa, M.B. Carneiro, L.M. dos Santos, C.C. Natale, M.E. Resende, D.M. Mosser, L.Q. Vieira, IL-18 contributes to susceptibility to Leishmania amazonensis infection by macrophage-independent mechanisms, Cytokine 74(2) (2015) 327-330.","DOI":"10.1016\/j.cyto.2015.01.021"},{"issue":"616","key":"10.1016\/j.cyto.2020.155297_b0350","article-title":"EBI-3 Chain of IL-35 along with TGF-\u03b2 synergistically regulate anti-leishmanial","volume":"10","author":"Asad","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155297_b0355","doi-asserted-by":"crossref","unstructured":"H. Hezarjaribi Ziaee, F. Ghaffarifar, A. Dalimi, Z. Sharifi, O. Jorjani, Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB\/c mice, Experimental parasitology 134(3) (2013) 341\u2013348.","DOI":"10.1016\/j.exppara.2013.03.012"},{"key":"10.1016\/j.cyto.2020.155297_b0360","doi-asserted-by":"crossref","unstructured":"A. Abdoli, N. Maspi, F. Ghaffarifar, i. diseases, Wound healing in cutaneous leishmaniasis: a double edged sword of IL-10 and TGF-\u03b2, Comparative immunology, microbiology 51 (2017) 15-26.","DOI":"10.1016\/j.cimid.2017.02.001"},{"key":"10.1016\/j.cyto.2020.155297_b0365","doi-asserted-by":"crossref","unstructured":"X.-Q. Wei, W. Niedbala, D. Xu, Z.-X. Luo, K.G. Pollock, J.M. Brewer, Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection, Immunology letters 94(1-2) (2004) 35-37.","DOI":"10.1016\/j.imlet.2004.04.001"},{"key":"10.1016\/j.cyto.2020.155297_b0370","doi-asserted-by":"crossref","unstructured":"H.W. Murray, Z. Xiang, X. Ma, Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase, The American journal of tropical medicine hygiene 74(6) (2006) 1013-1015.","DOI":"10.4269\/ajtmh.2006.74.1013"},{"key":"10.1016\/j.cyto.2020.155297_b0375","doi-asserted-by":"crossref","unstructured":"K.J. Bryson, X.-Q. Wei, J. Alexander, Interleukin-18 enhances a Th2 biased response and susceptibility to Leishmania mexicana in BALB\/c mice, Microbes infection 10(7) (2008) 834-839.","DOI":"10.1016\/j.micinf.2008.03.009"},{"key":"10.1016\/j.cyto.2020.155297_b0380","doi-asserted-by":"crossref","unstructured":"P. D'Agostino, S. Milano, F. Arcoleo, G. Di Bella, M. La Rosa, V. Ferlazzo, R. Caruso, N. Chifari, G. Vitale, S. Mansueto, E. Cillari, Interleukin-15, as Interferon-gamma, Induces the Killing of Leishmania infantum in Phorbol-Myristate-Acetate-Activated Macrophages Increasing Interleukin-12, 60(6) (2004) 609-614.","DOI":"10.1111\/j.0300-9475.2004.01522.x"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:41Z","timestamp":1760907581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620303136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":76,"alternative-id":["S1043466620303136"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155297","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A historical review of the role of cytokines involved in leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155297"}}